Pancreatic Cancer Research

ResearcherPeking University Third HospitalNo recent work listed

Lingfu Zhang

Matched on ORCID iD 0000-0002-4794-7678; OpenAlex author ID A5091822072. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2016: 5 papers · 2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: none · 2021: none · 2022: 1 paper

Papers 11

  1. Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14174243↗
  2. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Co-author DOI 10.1007/s11306-019-1550-1↗
  3. Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer. Co-author DOI 10.2147/cmar.s210332↗
  4. Serum Derived Exosomes From Pancreatic Cancer Patients Promoted Metastasis: An iTRAQ-Based Proteomic Analysis. Co-author DOI 10.2147/ott.s229494↗
  5. G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.2147/cmar.s165226↗
  6. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.2147/ott.s142022↗
  7. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis. First author DOI 10.1097/md.0000000000004932↗
  8. Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis. First author DOI 10.1186/s12957-016-0888-3↗
  9. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). First author DOI 10.18632/oncotarget.11031↗
  10. Parasympathetic neurogenesis is strongly associated with tumor budding and correlates with an adverse prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.21147/j.issn.1000-9604.2016.02.05↗
  11. High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.2147/ott.s111382↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunhui Yuan · 8 shared papers, 2016–2022 · strength 0.76
  2. Dianrong Xiu · 8 shared papers, 2016–2022 · strength 0.71
  3. Lianyuan Tao · 8 shared papers, 2016–2019 · strength 0.70
  4. Dianrong Xiu · 3 shared papers, 2016–2019 · strength 0.28
  5. Bin Jiang · 4 shared papers, 2016–2018 · strength 0.27
  6. Piaoe Zeng · 1 shared paper, 2022 · strength 0.16
  7. Chao Qu · 1 shared paper, 2022 · strength 0.16
  8. Huishu Yuan · 1 shared paper, 2022 · strength 0.16
  9. Jun Zhan · 2 shared papers, 2016–2018 · strength 0.15
  10. Puxian Tang · 1 shared paper, 2019 · strength 0.12
  11. Lijun Zhong · 1 shared paper, 2019 · strength 0.10
  12. Deyu Li · 1 shared paper, 2019 · strength 0.10
  13. Juntuo Zhou · 1 shared paper, 2019 · strength 0.10
  14. Wendi Li · 1 shared paper, 2017 · strength 0.10
  15. Hongquan Zhang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.